Remodulin 10 mg (Treprostinil (Treprostinil Sodium) SOLUTION) 10 MG

Remodulin 10 mg is a solution for intravenous use, containing treprostinil sodium. It is commonly used for managing certain cardiovascular conditions. This medication is designed to support vascular health and improve circulation.

Strength

10 MG

Pack Size

20ML

Manufacturer / TM Owner

UNITED THERAPEUTICS CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Remodulin 10 mg is primarily used to treat conditions related to pulmonary arterial hypertension. Treprostinil sodium, the active ingredient, works to dilate blood vessels and improve blood flow. This can help alleviate symptoms associated with reduced vascular function and enhance overall cardiovascular health.

Side Effects

Common effects of Remodulin 10 mg may include changes in blood pressure, headaches, and dizziness. Some users might experience flushing or nausea. These effects can vary depending on individual health conditions and other factors.

Precautions & Warnings

Remodulin 10 mg should be handled with care, following the instructions provided by a healthcare professional. It is important to store the solution properly and use it as directed. Always inform your healthcare provider about any existing medical conditions or medications you are taking.

Avoid Interactions

Remodulin 10 mg may interact with other medications, including those that affect blood pressure or blood flow. It is advisable to avoid alcohol while using this medication. Always consult a healthcare professional before combining Remodulin with other treatments.

Frequently Asked Questions

Remodulin 10 mg is used to manage symptoms of pulmonary arterial hypertension by improving blood flow and vascular function.

Remodulin 10 mg is administered intravenously. Follow the specific instructions provided by your healthcare professional for proper use.

Common side effects may include headaches, dizziness, flushing, and nausea. Individual experiences can vary.

Remodulin 10 mg may interact with other medications. Consult your healthcare provider before combining it with other treatments.

Store Remodulin 10 mg according to the instructions provided, typically in a cool, dry place away from direct sunlight.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.